WNC Stock Analysis: Wabash National | NYSE
Farm & Heavy Construction Machinery | NYSE, USA | Market Cap: 541m USD | 12M Return: 31.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.4M
Qual. Beats: -2
Rev. Trend: -99.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Wabash National Corporation (NYSE: WNC) is a U.S.-based manufacturer of engineered solutions serving the transportation, logistics, and infrastructure industries. Founded in 1985 and headquartered in Lafayette, Indiana, the company operates through two reportable segments: Transportation Solutions, which produces dry van, platform, refrigerated, and tank trailers along with a range of truck bodies, and Parts & Services, which provides aftermarket components, repair, maintenance, and complementary offerings such as stainless steel tanks, silos, and mixers for dairy, food and beverage, pharmaceutical, chemical, and biotech end markets. The company sells under multiple brands including Wabash, DuraPlate, AeroSkirt, and EcoNex, and is also developing a digital marketplace for the transportation and logistics distribution industry.
The company sits within the heavy transportation equipment sub-industry, a capital goods segment whose demand is closely tied to freight volumes, truck tonnage, and the capital spending cycles of fleet operators. Its Parts & Services business is intended to provide a more recurring revenue stream that is less cyclical than new trailer sales, while its truck body offerings position the company in the last-mile delivery and parcel logistics supply chain associated with e-commerce growth.
- Trailer demand softens as freight tonnage and rates decline
- Parts & Services margins expand with aftermarket mix
- Last-mile delivery truck bodies grow with e-commerce demand
| Net Income: -64.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -8.49 > 1.0 |
| NWC/Revenue: 7.95% < 20% (prev 13.36%; Δ -5.41% < -1%) |
| CFO/TA -0.02 > 3% & CFO -21.7m > Net Income -64.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (40.7m) vs 12m ago -5.45% < -2% |
| Gross Margin: 1.99% > 18% (prev 11.46%; Δ -9.47% > 0.5%) |
| Asset Turnover: 110.8% > 50% (prev 128.1%; Δ -17.25% > 0%) |
| Interest Coverage Ratio: -1.18 > 6 (EBIT TTM -61.9m / Interest Expense TTM 52.6m) |
| A: 0.09 (Total Current Assets 469.3m - Total Current Liabilities 352.7m) / Total Assets 1.23b |
| B: 0.21 (Retained Earnings 255.1m / Total Assets 1.23b) |
| C: -0.05 (EBIT TTM -61.9m / Avg Total Assets 1.32b) |
| D: 0.35 (Book Value of Equity 320.6m / Total Liabilities 907.4m) |
| Altman-Z'' = 1.35 = BB |
| DSRI: 1.04 (Receivables 160.2m/190.6m, Revenue 1.47b/1.81b) |
| GMI: 5.76 (GM 11.46% / 1.99%) |
| AQI: 1.28 (AQ_t 0.38 / AQ_t-1 0.30) |
| SGI: 0.81 (Revenue 1.47b / 1.81b) |
| TATA: -0.03 (NI -64.6m - CFO -21.7m) / TA 1.23b) |
| Beneish M = 1.34 (Cap -4..+1) = D |
As of July 29, 2026, the stock is trading at USD 13.22 with a total of 587,964 shares traded. Over the past week, the price has changed by -0.38%, over one month by -3.27%, over three months by +51.66% and over the past year by +31.15%.
Current recommended Stop Loss: 12.20 (which is 7.7% or 1.4 ATR below the current price).
Wabash National has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy WNC.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 22.5 | 70.2% |
P/E Forward = 8.5616
P/S = 0.3703
P/B = 1.6923
P/EG = 0.725
Revenue TTM = 1.47b USD
EBIT TTM = -61.9m USD
EBITDA TTM = -3.18m USD
Long Term Debt = 498.0m USD (from longTermDebt, last quarter)
Short Term Debt = 10.0m USD (from shortTermDebt, last quarter)
Debt = 541.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 10.0m
Net Debt = 497.5m USD (calculated: Debt 541.0m - CCE 43.4m)
Enterprise Value = 1.04b USD (541.0m + Debt 541.0m - CCE 43.4m)
Interest Coverage Ratio = -1.18 (Ebit TTM -61.9m / Interest Expense TTM 52.6m)
EV/FCF = -25.24x (Enterprise Value 1.04b / FCF TTM -41.2m)
FCF Yield = -3.96% (FCF TTM -41.2m / Enterprise Value 1.04b)
FCF Margin = -2.81% (FCF TTM -41.2m / Revenue TTM 1.47b)
Net Margin = -4.41% (Net Income TTM -64.6m / Revenue TTM 1.47b)
Gross Margin = 1.99% ((Revenue TTM 1.47b - Cost of Revenue TTM 1.44b) / Revenue TTM)
Gross Margin QoQ = -3.49% (prev -5.41%)
Tobins Q-Ratio = 0.84 (Enterprise Value 1.04b / Total Assets 1.23b)
Interest Expense / Debt = 9.72% (Interest Expense 52.6m / Debt 541.0m)
Taxrate = 25.26% (71.5m / 283.2m)
NOPAT = -46.3m (EBIT -61.9m * (1 - 25.26%)) [loss with tax shield]
Current Ratio = 1.33 (Total Current Assets 469.3m / Total Current Liabilities 352.7m)
Debt / Equity = 1.69 (Debt 541.0m / totalStockholderEquity, last quarter 320.6m)
Debt / EBITDA = -156.4 (out of range, set to none) (Net Debt 497.5m / EBITDA -3.18m)
Debt / FCF = -12.09 (negative FCF - burning cash) (Net Debt 497.5m / FCF TTM -41.2m)
Total Stockholder Equity = 373.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.89% (Net Income -64.6m / Total Assets 1.23b)
RoE = -17.32% (Net Income TTM -64.6m / Total Stockholder Equity 373.0m)
RoCE = -7.11% (EBIT -61.9m / Capital Employed (Equity 373.0m + L.T.Debt 498.0m))
RoIC = -5.49% (negative operating profit) (NOPAT -46.3m / Invested Capital 843.0m)
WACC = 8.50% (E(541.0m)/V(1.08b) * Re(9.73%) + D(541.0m)/V(1.08b) * Rd(9.72%) * (1-Tc(0.25)))
Discount Rate = 9.73% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.50 | Cagr: -6.09%
[DCF] Fair Price = unknown (Cash Flow -41.2m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -1.07 | # QB: -2
Revenue Correlation: -99.11 | Revenue CAGR: -20.80% | SUE: -0.75 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.56 | Chg30d=-27.27% | Revisions=-40% | Analysts=2
EPS next Quarter (2026-09-30): EPS=-0.13 | Chg30d=+18.75% | Revisions=-40% | Analysts=2
EPS current Year (2026-12-31): EPS=-1.76 | Chg30d=-0.86% | Revisions=-25% | GrowthEPS=+17.9% | GrowthRev=+2.3%
EPS next Year (2027-12-31): EPS=1.42 | Chg30d=-9.55% | Revisions=+0% | GrowthEPS=+180.4% | GrowthRev=+27.9%
[Analyst] Revisions Ratio: -50% (up=1, down=6)